PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2015Scientific Reports158 citationsOpen Access

Phytonutrient diet supplementation promotes beneficial Clostridia species and intestinal mucus secretion resulting in protection against enteric infection

MWMarta WlodarskaMerck & Co., Inc., Rahway, NJ, USA (United States)BWBenjamin P. WillingUniversity of AlbertaDBDavid M. BravoDépartement Santé Animale

Key Points

  • This research aims to evaluate how phytonutrient supplementation influences mucosal immune responses and protects against enteric infections.
  • Mice treated with six different phytonutrients: anethol, carvacrol, cinnamaldehyde, eugenol, capsicum oleoresin, and garlic extract.
  • Changes in colonic gene expression and mucus production were assessed post-treatment.
  • Microbiota composition was analyzed to determine changes due to eugenol treatment.
  • Eugenol treatment significantly stimulated the production of the inner mucus layer, enhancing the mucosal barrier against microbes.
  • Eugenol increased the abundance of specific Clostridia families in the intestinal microbiota.
  • Eugenol conferred colonization resistance to the enteric pathogen Citrobacter rodentium.

Abstract

Plant extracts, or phytonutrients, are used in traditional medicine practices as supplements to enhance the immune system and gain resistance to various infectious diseases and are used in animal production as health promoting feed additives. To date, there are no studies that have assessed their mechanism of action and ability to alter mucosal immune responses in the intestine. We characterized the immunomodulatory function of six phytonutrients: anethol, carvacrol, cinnamaldehyde, eugenol, capsicum oleoresin and garlic extract. Mice were treated with each phytonutrient to assess changes to colonic gene expression and mucus production. All six phytonutrients showed variable changes in expression of innate immune genes in the colon. However only eugenol stimulated production of the inner mucus layer, a key mucosal barrier to microbes. The mechanism by which eugenol causes mucus layer thickening likely involves microbial stimulation as analysis of the intestinal microbiota composition showed eugenol treatment led to an increase in abundance of specific families within the Clostridiales order. Further, eugenol treatment confers colonization resistance to the enteric pathogen Citrobacter rodentium. These results suggest that eugenol acts to strengthen the mucosal barrier by increasing the thickness of the inner mucus layer, which protects against invading pathogens and disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wlodarska et al. (2015) studied this question.

synapsesocial.com/papers/69fa0406e4035ef331640287https://doi.org/10.1038/srep09253
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression1999 · 819 citations
  2. 2Bioactivity of phytochemicals in some lesser-known plants and their effects and potential applications in livestock and aquaculture production systems2007 · 492 citations
  3. 3Dietary plant extracts improve immune responses and growth efficiency of pigs experimentally infected with porcine reproductive and respiratory syndrome virus12013 · 83 citations
  4. 4Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.2009 · 98 citations
  5. 5A new mathematical model for relative quantification in real-time RT-PCR2001 · 35,209 citations